Glucocorticosteroids inhibit leukotriene production

Area of Science:

• Immunology
• Pharmacology

Background:

• Corticosteroids are vital anti-inflammatory drugs, but their precise mechanism of action, particularly on primed cells, remains unclear.
• While known to inhibit phospholipase A2 in unprimed cells, their effect on primed inflammatory cells is not well understood.

Purpose of the Study:

• To investigate the effects of mometasone furoate and beclomethasone dipropionate on basophil sulfidoleukotriene production.
• To compare the efficacy of these corticosteroids on primed peripheral blood mixed leukocytes (PBML) from atopic individuals.

Main Methods:

• PBML from atopic individuals (in-season and out-of-season) were incubated with mometasone furoate or beclomethasone dipropionate.
• Cells were primed with IL-3, then stimulated with calcium ionophore, buffer, allergen, or anti-IgE.
• Sulfidoleukotriene production was quantified to assess corticosteroid effects.

Main Results:

• Neither corticosteroid consistently inhibited sulfidoleukotriene production in anti-IgE-stimulated cells that were already releasing sulfidoleukotrienes.
• Both mometasone furoate and beclomethasone dipropionate significantly reduced sulfidoleukotriene production in IL-3 primed cells stimulated with calcium ionophore or allergen.
• Mometasone furoate demonstrated potent inhibition of anti-IgE-induced leukotriene production, with a lower inhibitory concentration (IC50) than beclomethasone dipropionate.

Conclusions:

• Mometasone furoate appears more effective than beclomethasone dipropionate in inhibiting sulfidoleukotriene production and potentially cellular priming.
• These findings suggest differential efficacy of corticosteroids in managing inflammatory responses in atopic conditions.